Granite Point Capital Management, L.P. Legend Biotech Corp Put Options Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
233Shares Held
59.8MCall Options Held
576KPut Options Held
366K-
Westfield Capital Management CO LP Boston, MA6.92MShares$219 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$189 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$181 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$119 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$93.6 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.29B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...